Mucins in pancreatic cancer and its microenvironment

Sukhwinder Kaur, Sushil Kumar, Navneet Momi, Aaron R. Sasson, Surinder K. Batra

Research output: Contribution to journalReview articlepeer-review

186 Scopus citations


Pancreatic cancer remains a lethal malignancy with poor prognosis owing to therapeutic resistance, frequent recurrence and the absence of treatment strategies that specifically target the tumour and its supporting stroma. Deregulated cell-surface proteins drive neoplastic transformations and are envisioned to mediate crosstalk between the tumour and its microenvironment. Emerging studies have elaborated on the role of mucins in diverse biological functions, including enhanced tumorigenicity, invasiveness, metastasis and drug resistance through their characteristic O-linked and N-linked oligosaccharides (glycans), extended structures and unique domains. Multiple mucin domains differentially interact and regulate different components of the tumour microenvironment. This Review discusses: the expression pattern of various mucins in the pancreas under healthy, inflammatory, and cancerous conditions; the context-dependent attributes of mucins that differ under healthy and pathological conditions; the contribution of the tumour microenvironment in pancreatic cancer development and/or progression; diagnostic and/or prognostic efficacy of mucins; and mucin-based therapeutic strategies. Overall, this information should help to delineate the intricacies of pancreatic cancer by exploring the family of mucins, which, through various mechanisms in both tumour cells and the microenvironment, worsen disease outcome.

Original languageEnglish (US)
Pages (from-to)607-620
Number of pages14
JournalNature Reviews Gastroenterology and Hepatology
Issue number10
StatePublished - Oct 2013

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology


Dive into the research topics of 'Mucins in pancreatic cancer and its microenvironment'. Together they form a unique fingerprint.

Cite this